Abstract
This study was done to characterize the clinical features, laboratory parameters and response to therapy and outcome of childhood hyperthyroidism. The evaluation included history, examination, laboratory investigations: serum T3 T4, TSH free T3, free T4 by RIA or immunochemiluminescence (IC), antithyroid antibodies by standard techniques, bone age (BA) by Greulich and Pyle’s method, clinical and laboratory response to treatment, and follow-up of 15 children with hyperthyroidism seen in past eight years. Age of onset, presentation, nature and duration of symptoms, family history, anthropometry and signs of hyperthyroidism were recorded. There were 10 girls and 5 boys (2∶1). Three families had a history of thyroid disorders. Mean ages of onset and presentation were 8.25±3.4 and 9.27±3.2 years respectively. Clinical features included weight loss, heat intolerance and sweating, diarrhoea, behavioral problems, ophthalmopathy and tachycardia. BA was advanced. serum T3 (mean=4.29±1.77 ng/mL), T4 (18.75±5.64 μg/dL), FT3 (7.11±4.58 pg/mL) and FT4 (2.93±0.29 ng/mL) were markedly elevated. TSH was suppressed. Anti-microsomal antibodies (AMA) and anti-thyroglobulin antibodies (ATG) were positive in five. They were started on standard treatment with carbimazole 0.5–0.7 mg kg1. Clinical and biochemical euthyroidism was achieved within 2.5 to 6 months in all, after which the drug was tapered, however, they required treatment for 2 years to 7.5 years. Four children were retreated for relapse and are now euthyroid and off treatment. Childhood hyperthyroidism requires long term treatment and careful monitoring. This study shows a remission rate of 67%.
Similar content being viewed by others
References
Desai MP. Disorders of thyroid gland in India.Indian J Pediatr 1997; 64: 11–20
Virmani A, Menon PSN, Karmarkar MG, Gopinath PG, Padhy AKet al. Profile of thyroid disorders in a referral center in North India.Indian Pediatr 1989; 265–269.
Hayles AB, Chaves-Carballo E. Diagnosis and treatment of exophthalmic goiter in children.Clin Pediatr 1967; 6: 681–685
Annamalai A, Shreekumar S, Vellayan P. Incidence of juvenile thyrotoxicosis in Madras, 1959–64.Indian J Pediatr 1965; 32: 294–300
Kochupillai N, Goswami R. Unique clinical features of thyrotoxicosis as seen in India.J Assoc Physicians India 2000; Suppl 1: 53–56.
Zimmerman D, Lteif. Thyrotoxicosis.Endocrinol Metab Clinics N Amer. 1998 March.
Lavard L, Rantov I, Perild Het al. Incidence of juvenile thyrotoxicosis in Denmark 1982–1988. A nation-wide study.Eur J Endocrinol 1994; 130: 565–568.
Suresh PA, Sebastian S, George A, Radhakrishnan K.Pediatr Neurol 1999; 20 (3): 192–194.
Zimmerman D, Gan Gaisano M. Hyperthyroidism in children and adolescents.Pediatr Clin N Amer 1990; 37: 1274–1295.
Hayles AB, Zimmerman D. Grave’s disease in childhood. In: Inghar SH, Braverman LE (eds.),Werner’s The Thyroid, 5th Ed, Philadelphia; JB Lippincot 1986; 1412–1428.
Robinson DC, Hall R, Munro DS. Grave’s Disease, An unusual complication: Raised intracranial pressure due to premature fusion of skull sutures.Arch Dis Child 1969; 44: 252–257.
Glaser NS, Slyne DM.J Clin Endocrinol Metab 1998; 83 (4): 1398–1409.
Barnes HV, Blizzard RM 1997. Antithyroid drug therapy for toxic diffuse goiter (Grave’s disease): Thirty years experience in children and adolescents.J Pediatr 91: 313–320.
Schulman M, Muhar I, Jorgensen EVet al. Autoimmune hyperthyroidism in prepubertal children and adolescents: Comparison of clinical and biochemical features at diagnosis and response to medical therapy.Thyroid 1997; 7: 755–760.
Vitti P, Rago Tet al. Clinical features of patients with Grave’s disease undergoing remission after antithyroid drug treatment.Thyroid 1997; 7: 369–375.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mokhashi, M.H., Desai, U. & Desai, M.P. Hyperthyroidism in children. Indian J Pediatr 67, 653–656 (2000). https://doi.org/10.1007/BF02762177
Issue Date:
DOI: https://doi.org/10.1007/BF02762177